[{"Assets_0_Q3_USD":2603727.0,"CommonStockSharesOutstanding_0_Q3_shares":30980658.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-6830774.0,"NetIncomeLoss_3_Q3_USD":-13195468.0,"NetIncomeLoss_1_Q3_USD":-2686065.0,"StockholdersEquity_0_Q3_USD":473898.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190515"}]